Cargando…
Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies
Ribavirin has been used widely to treat Lassa fever in West Africa since the 1980s. However, few studies have systematically appraised the evidence for its use. We conducted a systematic review of published and unpublished literature retrieved from electronic databases and gray literature from incep...
Autores principales: | Cheng, Hung-Yuan, French, Clare E., Salam, Alex P., Dawson, Sarah, McAleenan, Alexandra, McGuinness, Luke A., Savović, Jelena, Horby, Peter W., Sterne, Jonathan A.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9328902/ https://www.ncbi.nlm.nih.gov/pubmed/35876478 http://dx.doi.org/10.3201/eid2808.211787 |
Ejemplares similares
-
Time to reconsider the role of ribavirin in Lassa fever
por: Salam, Alex Paddy, et al.
Publicado: (2021) -
A Promising Candidate for a Lassa Fever Vaccine
Publicado: (2005) -
Lassa Fever in Travelers from West Africa, 1969–2016
por: Kofman, Aaron, et al.
Publicado: (2019) -
Absence of Nosocomial Transmission of Imported Lassa Fever during Use of Standard Barrier Nursing Methods
por: Grahn, Anna, et al.
Publicado: (2018) -
Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1–May 6, 2018
por: Ilori, Elsie A., et al.
Publicado: (2019)